Products of Vitamin D3 or 7-Dehydrocholesterol Metabolism by Cytochrome P450scc Show Anti-Leukemia Effects, Having Low or Absent Calcemic Activity
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cytochrome P450scc metabolizes vitamin D3 to 20-hydroxyvitamin D3 (20(OH)D3) and 20,23(OH)(2)D3, as well as 1-hydroxyvitamin D3 to 1alpha,20-dihydroxyvitamin D3 (1,20(OH)(2)D3). It also cleaves the side chain of 7-dehydrocholesterol producing 7-dehydropregnenolone (7DHP), which can be transformed to 20(OH)7DHP. UVB induces transformation of the steroidal 5,7-dienes to pregnacalciferol (pD) and a lumisterol-like compounds (pL). METHODS AND FINDINGS: To define the biological significance of these P450scc-initiated pathways, we tested the effects of their 5,7-diene precursors and secosteroidal products on leukemia cell differentiation and proliferation in comparison to 1alpha,25-dihydroxyvitamin D3 (1,25(OH)(2)D3). These secosteroids inhibited proliferation and induced erythroid differentiation of K562 human chronic myeloid and MEL mouse leukemia cells with 20(OH)D3 and 20,23(OH)(2)D3 being either equipotent or slightly less potent than 1,25(OH)(2)D3, while 1,20(OH)(2)D3, pD and pL compounds were slightly or moderately less potent. The compounds also inhibited proliferation and induced monocytic differentiation of HL-60 promyelocytic and U937 promonocytic human leukemia cells. Among them 1,25(OH)(2)D3 was the most potent, 20(OH)D3, 20,23(OH)(2)D3 and 1,20(OH)(2)D3 were less active, and pD and pL compounds were the least potent. Since it had been previously proven that secosteroids without the side chain (pD) have no effect on systemic calcium levels we performed additional testing in rats and found that 20(OH)D3 had no calcemic activity at concentration as high as 1 microg/kg, whereas, 1,20(OH)(2)D3 was slightly to moderately calcemic and 1,25(OH)(2)D3 had strong calcemic activity. CONCLUSIONS: We identified novel secosteroids that are excellent candidates for anti-leukemia therapy with 20(OH)D3 deserving special attention because of its relatively high potency and lack of calcemic activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It also shows anti-cancer and anti-tumor activities that are dependent on the cell-type lineage [57,77,112,119–121].”
From Novel activities of CYP11A1 and their potential physiological significance (2015) · cites this paper as [77]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“but unlike 1α,25(OH)2D3 and 25(OH)D3, pharmacological doses do not raise serum calcium in rodents [68–70].”
From The serum vitamin D metabolome: what we know and what is still to discover (2019) · cites this paper as [69]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Finally, CYP11A1-derived secosteroidal hydroxy-derivatives and Δ7steroids are biologically active when administered in vitro in a manner dependent on the structure of the compound and the lineage of the target cells, suggesting physiological roles for these metabolites.”
From Novel activities of CYP11A1 and their potential physiological significance (2015) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“These novel secosteroids lacking the C1α-hydroxyl group are noncalcemic, while 1α,20S(OH)2D3 displays low calcemic activity [68–70, 175].”
From The serum vitamin D metabolome: what we know and what is still to discover (2019) · cites this paper as [69]
In the citing paper
“20(OH)D3 at a doses as high as 3.0 μg/kg had no calcemic activity in rats whereas 1,25(OH)2D3 at the same dose raised calcium to 16.0 ± 1.2 mg/dL [84].”
From The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions (2014) · cites this paper as [84]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Self-citationHolick, M. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1678s · Cited by 3,198
Self-citationOverview of general physiologic features and functions of vitamin D
DeLuca, H. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1689s · Cited by 2,327
Vitamin D: a millenium perspective
Holick, M. F. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10338 · Cited by 1,319 · cited 2×
“This is consistent with a fundamental role of the hydroxyl group at the 1 alpha-position of vitamin D for the regulation of serum calcium levels [8,21].”
BackgroundSelf-citationNoncalcemic Actions of Vitamin D Receptor Ligands
Nagpal, S., Na, S., & Rathnachalam, R. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0002 · Cited by 961
Gallagher, R., Collins, S., Trujillo, J., McCredie, K., Ahearn, M., Tsai, S., Metzgar, R., Aulakh, G., Ting, R., Ruscetti, F., et al. (1979) · Blood · doi:10.1182/blood.v54.3.713.713 · Cited by 925
The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand
Rochel, N., Wurtz, J. M., Mitschler, A., Klaholz, B., & Moras, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80413-x · Cited by 842 · cited 1×
“Molecular modeling studies To understand the potential binding mode of 20S(OH)D3 in VDR, we selected the crystal structure of the VDR complex with calcitriol (PDB code: 1DB1)[35]and performed molecular modeling studies using Schrodinger Suite 2009 (Schrodinger Inc.”
MethodThiboutot, D., Gilliland, K., Cong, Z., Jabara, S., McAllister, J. M., Sivarajah, A., & Clawson, G. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12244.x · Cited by 301 · cited 1×
“Interestingly the number of tissues in which expression of P450scc has been identified is growing and includes bone, thymus, skin and brain as examples [30,39–44], raising the possibility of local production of the ligands identified in this study in the bone marrow environment.”
Background1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation.
Bikle, D. D., Nemanic, M. K., Gee, E., & Elias, P. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112609 · Cited by 269
Slominski, A., Zjawiony, J., Wortsman, J., Semak, I., Stewart, J., Pisarchik, A., Sweatman, T., Marcos, J., Dunbar, C., & C. Tuckey, R. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04356.x · Cited by 243 · cited 8×
“which can be further hydroxylated by classical steroidogenic enzymes to different steroidal 5,7-dienal hydroxy-products [29,30].”
BackgroundMethodSelf-citation
Cited by
Vitamin D metabolism, mechanism of action, and clinical applications
Bikle, D. D. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.12.016 · Cited by 1,933
Slominski (2012) · doi:10.1007/978-3-642-19683-6_1 · Cited by 461
Self-citationKey role of CRF in the skin stress response system
Slominski, A. T., Zmijewski, M. A., Zbytek, B., Tobin, D. J., Theoharides, T. C., & Rivier, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1092 · Cited by 400
Self-citationNovel activities of CYP11A1 and their potential physiological significance
Slominski, A. T., Li, W., Kim, T.-K., Semak, I., Wang, J., Zjawiony, J. K., & Tuckey, R. C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.010 · Cited by 292
“Pregnalumisterol and some synthetic hydroxylumisterol 3 derivatives exhibit biological activity [76,77] further suggesting that metabolism of lumisterol by CYP11A1 in the skin may produce metabolites with physiological activity.”
Self-citationCytochromes P450 are essential players in the vitamin D signaling system
Schuster, I. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.06.022 · Cited by 284
Metadata
- Authors
- Slominski, A. T., Janjetovic, Z., Fuller, B. E., Zmijewski, M. A., Tuckey, R. C., Nguyen, M. N., Sweatman, T., Li, W., Zjawiony, J., Miller, D., Chen, T. C., Lozanski, G., & Holick, M. F.
- Affiliations
- University of Tennessee Health Science Center (US)
- Gdańsk Medical University (PL)
- The University of Western Australia (AU)
- University of Mississippi (US)
- Boston University (US)
- The Ohio State University (US)
- Corresponding author
- Slominski, Andrzej T.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-03-26
- Volume
- 5
- Issue
- 3
- Pages
- e9907
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2845617
- OpenAlex
- W2020048876
- Cited by
- 149
- References
- 54
- Citations by year
- 2025: 3 · 2024: 9 · 2023: 7 · 2022: 13 · 2021: 12 · 2020: 11 · 2019: 4 · 2018: 11 · 2017: 9 · 2016: 9 · 2015: 12 · 2014: 12 · 2013: 7 · 2012: 13
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- OpenBU (Boston University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- U.S. Public Health Service (R01A052190)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK040561)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052190)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Photodynamic Therapy Research Studies
- Keywords
- vitamin D3 metabolism, 7-dehydrocholesterol, cytochrome P450scc, secosteroids, lumisterol, leukemia cell differentiation, leukemia cell proliferation, calcemic activity, chronic myeloid leukemia, promyelocytic leukemia
- MeSH terms
- Animals, Antineoplastic Agents, Calcifediol, Cholecalciferol, Cholesterol Side-Chain Cleavage Enzyme, Dehydrocholesterols, Humans, Hypercalcemia, Pregnenolone, Gene Expression Regulation, Leukemic, HL-60 Cells, U937 Cells, Cell Line, Tumor, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Products of Vitamin D3 or 7-Dehydrocholesterol Metabolism by Cytochrome P450scc Show Anti-Leukemia Effects, Having Low or Absent Calcemic Activity. https://app.cochat.ai/papers/10.1371/journal.pone.0009907
- The paper
- Slominski, A. T., Janjetovic, Z., Fuller, B. E., Zmijewski, M. A., Tuckey, R. C., Nguyen, M. N., Sweatman, T., Li, W., Zjawiony, J., Miller, D., Chen, T. C., Lozanski, G., & Holick, M. F. (2010). Products of Vitamin D3 or 7-Dehydrocholesterol Metabolism by Cytochrome P450scc Show Anti-Leukemia Effects, Having Low or Absent Calcemic Activity. PLoS ONE. https://doi.org/10.1371/journal.pone.0009907
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.